证券记录 · 已归档季度
REGN
Regeneron Pharmaceuticals, Inc. · Healthcare · Biotechnology
27被追踪持有人
-1Δ持有人
48.96M持有股份
$27.52B报告持仓市值
+0新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -3.6% ·
股份流向 -1.3% ·
净新建仓位 -7.4%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 169 | -1 | 76.12M | $47.53B | +5 | −5 |
| Q1 2026 | 172 | -4 | 77.87M | $60.04B | +2 | −7 |
| Q4 2025 | 175 | 0 | 81.03M | $62.54B | +1 | — |
| Q3 2025 | 27 | -1 | 48.96M | $27.52B | — | −2 |
| Q2 2025 | 26 | +2 | 40.24M | $21.12B | +3 | −1 |
| Q1 2025 | 21 | +1 | 16.62M | $10.53B | +1 | — |
| Q4 2024 | 20 | -1 | 17.24M | $12.28B | — | −1 |
| Q3 2024 | 20 | +1 | 13.10M | $13.76B | +2 | −1 |
| Q2 2024 | 19 | — | 13.77M | $14.47B | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 9.05M | -4.0% | $5.09B | 0.1% | ▼ Trim | 2 | SEC ↗ ×7 |
| 2 | BlackRock ✦ (被动) | 8.84M | -4.7% | $4.97B | 0.1% | ▼ Trim | 2 | SEC ↗ ×22 |
| 3 | JPMorgan Chase ✦ | 8.14M | — | $4.58B | 0.1% | n/c | 1 | SEC ↗ ×42 |
| 4 | State Street Global Advisors ✦ (被动) | 4.69M | -2.9% | $2.64B | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 5 | Dodge & Cox ✦ | 4.55M | +18.9% | $2.56B | 1.4% | ▲ Add | 6 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 2.54M | +2.9% | $1.42B | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Capital World Investors ✦ | 2.00M | +1.6% | $1.12B | 0.2% | ▲ Add | 6 | SEC ↗ |
| 8 | Fidelity (FMR) ✦ | 1.94M | -41.8% | $1.09B | 0.1% | ▼ Trim | 2 | SEC ↗ ×4 |
| 9 | Morgan Stanley ✦ | 1.45M | — | $815.84M | 0.0% | n/c | 1 | SEC ↗ ×17 |
| 10 | Goldman Sachs Group ✦ | 952.84K | — | $535.75M | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 11 | D. E. Shaw & Co. ✦ | 861.59K | +10.8% | $484.45M | 0.4% | ▲ Add | 6 | SEC ↗ ×2 |
| 12 | T. Rowe Price ✦ | 804.91K | +5.0% | $452.58M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 13 | AQR Capital Management ✦ | 721.35K | +528.7% | $405.60M | 0.3% | ▲ Add | 6 | SEC ↗ ×7 |
| 14 | Two Sigma Investments ✦ | 469.90K | -6.0% | $264.21M | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 15 | Marshall Wace ✦ | 386.88K | +61.3% | $217.53M | 0.2% | ▲ Add | 6 | SEC ↗ ×3 |
| 16 | Renaissance Technologies ✦ | 275.16K | +510.6% | $154.72M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 235.38K | +164.3% | $132.35M | 0.5% | ▲ Add | 6 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 230.23K | -66.2% | $129.45M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 19 | Point72 Asset Management ✦ | 201.50K | +40.8% | $113.30M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 20 | Millennium Management ✦ | 201.08K | -40.6% | $113.06M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 21 | Arrowstreet Capital ✦ | 192.58K | +3076.4% | $108.28M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 22 | Adage Capital Partners ✦ | 123.05K | +28.7% | $69.19M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 23 | Gotham Asset Management ✦ | 84.23K | +211.9% | $47.36M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 24 | ARK Investment Management ✦ | 12.14K | -3.7% | $6.83M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 25 | Wellington Management ✦ | 7.62K | -89.3% | $4.28M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 26 | Fisher Asset Management ✦ | 4.64K | +6.5% | $2.61M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 27 | GAMCO Investors ✦ | 646 | +7.3% | $363,226 | 0.0% | ▲ Add | 6 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Norges Bank | $628.15M | 曾为 0.1% |
| Scion Asset Management | $7.88M | 曾为 14.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,385 持有人, 83.52M 股份, $61.43B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 02
Guarini Kathryn
Director · 400 股 · $340,000
Aug 10
Guarini Kathryn
Director · 400 股 · $320,000
Aug 10
Zoghbi Huda Y
Director · 800 股 · $640,000
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据